Author

Vaishali Vishwakarma

Central Drug Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:biophysical modeling· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Bushra QaziiD· 3 shared Sourav HaldariD· 3 shared Hirak ChakrabortyiD· 2 shared Chetan D. MeshramiD· 1 shared Garima Pant· 1 shared Gourab Prasad PattnaikiD· 1 shared Kalyan MitraiD· 1 shared Manbit Subhadarsi Panda· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiophysics

Bushra QaziORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Host cell plasma membrane-derived vesicles efficiently inhibit in vitro Influenza A virus infection in a size-dependent manner

Bushra Qazi, Vaishali Vishwakarma, V. Ravi Kumar, Garima Pant, Kalyan Mitra, Raj Kamal Tripathi, Sourav Haldar

This study shows that plasma membrane-derived vesicles inhibit Influenza A virus infection in a size-dependent manner by competitively binding to hemagglutinin.

bioRxiv · May 4, 2026 · PreprintBiochemistry

Tryptophan-aspartic acid containing peptide analog from coronin 1 inhibits model membrane fusion and enveloped viral infection in cells

Swaratmika Pandia, Bushra Qazi, Vaishali Vishwakarma, Shruti Gautam, Chetan D. Meshram, Hirak Chakraborty, Sourav Haldar

The paper designs a tryptophan-aspartic acid peptide analog, mGG21, that inhibits membrane fusion and enveloped viral infection by altering membrane physical properties.

Langmuir · Sep 22, 2025Peer-reviewedBiophysics

Developing peptide-based fusion inhibitors as an antiviral strategy utilizing Coronin 1 as a template

Manbit Subhadarsi Panda, Bushra Qazi, Vaishali Vishwakarma, Gourab Prasad Pattnaik, Sourav Haldar, Hirak Chakraborty

This paper develops a peptide-based fusion inhibitor, mTG-23, derived from coronin 1, which inhibits membrane fusion in vitro and reduces influenza A virus infection in cell lines.

RSC Medicinal Chemistry · Oct 2, 2024Peer-reviewedBiophysics